Popular New
- Safety of Marketed Cancer Supportive Care Biosimilars in the US: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database536 daysBioDrugsRead
- Biosimilar Perceptions Among Healthcare Professionals and Commercial Medical Benefit Policy Analysis in the United States544 daysBioDrugsRead
- Administration of CD4 + CD25 high CD127− FoxP3 + Regulatory T Cells for Relapsing-Remitting Multiple Sclerosis: A Phase 1 Study544 daysBioDrugsRead
- Budget Impact Analysis of the Introduction of Rituximab and Trastuzumab Intravenous Biosimilars to EU-5 Markets556 daysBioDrugsRead
- Effect of Treatment with the PD-1/PD-L1 Inhibitors on Key Health Outcomes of Cancer Patients563 daysBioDrugsRead
- A Look at the History of Biosimilar Adoption: Characteristics of Early and Late Adopters of Infliximab and Etanercept Biosimilars in Subregions of England, Scotland and Wales - A Mixed Methods Study569 daysBioDrugsRead
- Systematic Review and Principal Components Analysis of the Immunogenicity of Adalimumab570 daysBioDrugsRead
- Emerging Targeted Therapies for Neuromyelitis Optica Spectrum Disorders570 daysBioDrugsRead
- Acknowledgement to Referees600 daysBioDrugsRead
- European Stakeholder Learnings Regarding Biosimilars: Part I—Improving Biosimilar Understanding and Adoption607 daysBioDrugsRead
- Checkpoint Inhibitors in Gynecological Malignancies: Are we There Yet?607 daysBioDrugsRead
- Focused Update on AAV-Based Gene Therapy Clinical Trials for Inherited Retinal Degeneration608 daysBioDrugsRead
- Switching to Biosimilar SDZ-ADL in Patients with Moderate-to-Severe Active Rheumatoid Arthritis: 48-Week Efficacy, Safety and Immunogenicity Results From the Phase III, Randomized, Double-Blind ADMYRA Study612 daysBioDrugsRead
- Clinical Trials of IL-12/IL-23 Inhibitors in Inflammatory Bowel Disease615 daysBioDrugsRead
- European Stakeholder Learnings Regarding Biosimilars: Part II—Improving Biosimilar Use in Clinical Practice626 daysBioDrugsRead
- The Immunotherapy Landscape in Renal Cell Carcinoma628 daysBioDrugsRead
- Approval of Itolizumab for COVID-19: A Premature Decision or Need of The Hour?628 daysBioDrugsRead
- Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease after Switching from Originator Infliximab: Exploratory Analyses from the NOR-SWITCH Main and Extension Trials648 daysBioDrugsRead
- PF-06410293: An Adalimumab Biosimilar652 daysBioDrugsRead
- Drug Survival of Biologics in Treating Ankylosing Spondylitis: A Systematic Review and Meta-analysis of Real-World Evidence653 daysBioDrugsRead
- Changes in Anthropometric Parameters After Anti-TNFα Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis654 daysBioDrugsRead
- Monoclonal Antibody-Based Therapies for Myasthenia Gravis660 daysBioDrugsRead
- Innovative Therapies for Hemoglobin Disorders663 daysBioDrugsRead
- Cell Therapy for Idiopathic Pulmonary Fibrosis: Rationale and Progress to Date664 daysBioDrugsRead
- Correction to: Assessment of Structural and Functional Comparability of Biosimilar Products: Trastuzumab as a Case Study667 daysBioDrugsRead
- Immunotherapy in Breast Cancer: Current Practice and Clinical Challenges670 daysBioDrugsRead
- Prediction of Immunogenicity of Therapeutic Proteins: Validity of Computational Tools4558 daysBioDrugsRead
- Monoclonal Antibodies Targeting Vascular Endothelial Growth Factor: Current Status and Future Challenges in Cancer Therapy4673 daysBioDrugsRead
- Therapeutic Potential of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Inhibitors in Polycystic Kidney Disease4695 daysBioDrugsRead
- Application of Glatiramer Acetate to Neurodegenerative Diseases beyond Multiple Sclerosis: The Need for Disease-Specific Approaches5044 daysBioDrugsRead
- Understanding and Applying Regulatory Guidance on the Nonclinical Development of Biotechnology-Derived Pharmaceuticals5101 daysBioDrugsRead
- Fibroblast Growth Factor-21 as a Therapeutic Agent for Metabolic Diseases5269 daysBioDrugsRead
- Selective Targeting of Cancer Stem Cells: A New Concept in Cancer Therapeutics5391 daysBioDrugsRead
- RNAi Therapy for HIV Infection: Principles and Practicalities5631 daysBioDrugsRead
- Human Papillomavirus Quadrivalent (types 6, 11, 16, 18) Recombinant Vaccine (Gardasil): Profile Report5746 daysBioDrugsRead
Quick Link
- Medicine - All Feeds
- Allergology and Immunology
- Anatomy and Physiology
- Anesthesiology and Intensive Care
- Biochemistry
- Bioengineering
- Biophysics
- Biotechnology
- Cardiology
- Cardiothoracic Surgery
- Clinical Chemistry
- Clinical Medicine
- Complementary Medicine
- Cytology and Histology
- Dentistry
- Dermatology
- Endocrinology
- Forensic Medicine
- Gastroenterology
- General Practice
- Genetics
- Geriatrics
- Health services and Administration
- Hematology
- Infectious Diseases
- Internal Medicine
- Logopedics
- Medical Education and Humanities
- Medical Microbiology
- Medicine - Other
- Nephrology
- Neurology
- Neurosurgery
- Nursing
- Nutritional Sciences
- Obstetrics and Gynecology
- Occupational Health
- Oncology
- Ophthalmology
- Oral and Maxillofacial Surgery
- Orthopedics and Traumatology
- Otorhinolaryngology and Phoniatrics
- Pathology
- Pediatrics
- Pharmacology and Pharmacotherapy
- Physical and Rehabilitation Medicine
- Plastic Surgery
- Psychiatry
- Psychology
- Public Health
- Radiology
- Respiratory Medicine
- Rheumatology
- Sports Medicine
- Surgery
- Urology